Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies

BACKGROUND: The persistence of the SARS-CoV2 pandemic, partly due to the appearance of highly infectious variants, has made booster vaccinations necessary for vulnerable groups. Questions remain as to which cohorts require SARS-CoV2 boosters. However, there is a critical lack of data on the dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisen, Ulf M, Sümbül, Melike, Tran, Florian, Berner, Dennis K, Reid, Hayley M, Vullriede, Lena, Ciripoi, Maria, Longardt, Ann C, Hoff, Paula, Morrison, Peter J, Schneider, Verena E, Zeuner, Rainald, Schirmer, Jan H, Steinbach, Andrea, Nikolaus, Susanna, Gerdes, S, Schreiber, Stefan, Bacher, Petra, Hoyer, Bimba F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655347/
https://www.ncbi.nlm.nih.gov/pubmed/34880128
http://dx.doi.org/10.1136/rmdopen-2021-002008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655347/
https://www.ncbi.nlm.nih.gov/pubmed/34880128
http://dx.doi.org/10.1136/rmdopen-2021-002008

Ejemplares similares